1Carr A, Miller J, Law M, et al. A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome[J]. AIDS, 2000,14: F25 - 32.
2Carr A, Samaras K, Thorisdottir A, et al. Diagnosis, prediction, and natural course of HIV protease-inhibitor-associated lipodystrophy, hyperlipidemia,and diabetes mellitus [ J ] . Lancet, 1999, 353: 2893 -2899.
3Martinez E, Mocroft A, Garcia-Viejo MA, et al. Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study. Lancet 2001 ;357(9256) :592 -598.
4Friis-Moller N, Weber R, D' Arminio Monforte A, et al. Exposure to HAART is associated with an increased risk of myocardial infarction:the DAD Study[ abstract 130 ] [ R ]. 10th Conference on Retroviruses and Opportunistic Infectious, 2003 ( Feb 10 - 14), Boston.
5Gerster JC, Camus JP, Chave JP, et al. Multiple site avascular necrosis in HIV infected patients[ J ]. J Rheumatol, 1991,18 ( 2 ): 300 - 302.
6Holmberg S, Moorman A, Tong T, et al. For the HIV Outpatient Study(HOPS) Investigators. Protease inhibitor use and andverse cardiovascular outcomes in ambulatory HIV patients[abstract 698- T][R]. 9th Conference on Retroviruses and Opportunistic Infections,2002 ( Feb24 - 28), Seattle.
7Bozzette SA, Ake C, Carpenter A, et al. Cardio ad cerebrovascular outcomes with changing process of anti-HIV therapy in 36,766 US veterans[abstract LB-9] [R] .9th Conference on Retroviruses and Opportunistic Infections, 2002 ( Feb 24 - 28), Seattle.
8Hollmig KA,Beck SB,Doll DC.Severe bleeding complications in HIVpositive haemophiliac patients treated with protease inhibitors[J]. Eur J Med Res,2001,6(3) :112 - 114.
9Kodoth S, Bakashi S, Scimeca P, et al. Possible linkage of amprenavir with intracranial bleeding in an HIV-infected hemophiliac[J ] .AIDS Patient Care STDs,2001,15(7) :347 - 352.
10Wilde JT, Lee CA, Collins P, et al. Increased bleeding associated with protease inhibitor therapy in HIV-positive patients with bleeding disorders[J ]. Br J Haematol, 1999,107:556 - 559.
